Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 11 | 2018 | 2030 | 1.200 |
Why?
|
| Mothers | 5 | 2024 | 376 | 0.970 |
Why?
|
| Viral Load | 3 | 2015 | 407 | 0.860 |
Why?
|
| Dried Blood Spot Testing | 2 | 2015 | 27 | 0.860 |
Why?
|
| Anti-HIV Agents | 4 | 2015 | 347 | 0.860 |
Why?
|
| Malawi | 15 | 2019 | 340 | 0.770 |
Why?
|
| Drug Monitoring | 3 | 2015 | 286 | 0.740 |
Why?
|
| Prenatal Care | 3 | 2016 | 344 | 0.720 |
Why?
|
| Antiretroviral Therapy, Highly Active | 6 | 2015 | 255 | 0.660 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2023 | 503 | 0.640 |
Why?
|
| HIV-1 | 3 | 2015 | 492 | 0.640 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 915 | 0.630 |
Why?
|
| Health Care Costs | 2 | 2015 | 406 | 0.560 |
Why?
|
| RNA, Viral | 2 | 2015 | 499 | 0.470 |
Why?
|
| Sexual Behavior | 2 | 2015 | 231 | 0.470 |
Why?
|
| Schools, Medical | 1 | 2016 | 116 | 0.450 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 92 | 0.440 |
Why?
|
| Risk-Taking | 1 | 2015 | 94 | 0.440 |
Why?
|
| Reproductive Health | 1 | 2015 | 48 | 0.440 |
Why?
|
| Health Resources | 2 | 2015 | 127 | 0.430 |
Why?
|
| Abortion, Spontaneous | 3 | 2019 | 81 | 0.410 |
Why?
|
| Antibiotic Prophylaxis | 3 | 2019 | 114 | 0.410 |
Why?
|
| Education, Medical | 1 | 2016 | 292 | 0.370 |
Why?
|
| Interviews as Topic | 4 | 2015 | 451 | 0.350 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2013 | 261 | 0.340 |
Why?
|
| Breast Feeding | 1 | 2013 | 235 | 0.340 |
Why?
|
| Sex Work | 1 | 2010 | 4 | 0.330 |
Why?
|
| Health Personnel | 1 | 2015 | 547 | 0.320 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 706 | 0.310 |
Why?
|
| Malaria | 2 | 2007 | 95 | 0.300 |
Why?
|
| Adult | 23 | 2024 | 31120 | 0.300 |
Why?
|
| Pregnancy | 15 | 2024 | 7394 | 0.290 |
Why?
|
| Pelvic Infection | 2 | 2019 | 4 | 0.290 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 694 | 0.280 |
Why?
|
| Motivation | 1 | 2010 | 328 | 0.280 |
Why?
|
| AIDS Serodiagnosis | 1 | 2008 | 52 | 0.280 |
Why?
|
| Doxycycline | 2 | 2019 | 112 | 0.270 |
Why?
|
| Metronidazole | 2 | 2019 | 161 | 0.270 |
Why?
|
| Data Collection | 3 | 2019 | 370 | 0.270 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2018 | 66 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2013 | 502 | 0.260 |
Why?
|
| Poverty | 3 | 2024 | 454 | 0.260 |
Why?
|
| Stress, Psychological | 3 | 2024 | 538 | 0.250 |
Why?
|
| Adolescent | 15 | 2023 | 20725 | 0.240 |
Why?
|
| Young Adult | 11 | 2024 | 9993 | 0.220 |
Why?
|
| Female | 24 | 2024 | 70351 | 0.220 |
Why?
|
| Qualitative Research | 4 | 2016 | 704 | 0.210 |
Why?
|
| Unsafe Sex | 2 | 2015 | 23 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 901 | 0.190 |
Why?
|
| Perception | 2 | 2015 | 229 | 0.190 |
Why?
|
| Health Surveys | 3 | 2015 | 257 | 0.190 |
Why?
|
| Humans | 31 | 2024 | 130436 | 0.190 |
Why?
|
| Rural Health | 2 | 2015 | 46 | 0.180 |
Why?
|
| Sex Offenses | 1 | 2023 | 52 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 165 | 0.180 |
Why?
|
| Social Support | 1 | 2024 | 363 | 0.170 |
Why?
|
| Mental Health | 1 | 2024 | 370 | 0.160 |
Why?
|
| Students | 1 | 2023 | 250 | 0.160 |
Why?
|
| Chorioamnionitis | 1 | 2019 | 37 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 330 | 0.150 |
Why?
|
| Schistosoma haematobium | 1 | 2018 | 17 | 0.140 |
Why?
|
| Schistosomiasis haematobia | 1 | 2018 | 11 | 0.140 |
Why?
|
| Vesicovaginal Fistula | 1 | 2018 | 15 | 0.140 |
Why?
|
| Schistosomiasis | 1 | 2018 | 52 | 0.140 |
Why?
|
| Immunization | 1 | 2019 | 267 | 0.140 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2018 | 19 | 0.140 |
Why?
|
| Levonorgestrel | 1 | 2018 | 20 | 0.140 |
Why?
|
| Virus Shedding | 1 | 2018 | 75 | 0.140 |
Why?
|
| Contraceptive Agents, Female | 1 | 2018 | 31 | 0.140 |
Why?
|
| Cultural Characteristics | 2 | 2016 | 45 | 0.130 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 91 | 0.130 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 58 | 0.130 |
Why?
|
| Syringes | 1 | 2017 | 22 | 0.130 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2015 | 227 | 0.130 |
Why?
|
| Magnesium Sulfate | 1 | 2017 | 52 | 0.130 |
Why?
|
| HIV | 1 | 2018 | 174 | 0.130 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 169 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2019 | 357 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 2019 | 327 | 0.120 |
Why?
|
| Workload | 2 | 2015 | 149 | 0.120 |
Why?
|
| Obstetric Surgical Procedures | 1 | 2016 | 6 | 0.120 |
Why?
|
| Male | 10 | 2015 | 64471 | 0.120 |
Why?
|
| Social Stigma | 2 | 2016 | 78 | 0.120 |
Why?
|
| Pregnancy Complications | 2 | 2024 | 540 | 0.120 |
Why?
|
| Middle Aged | 9 | 2018 | 28395 | 0.120 |
Why?
|
| Diabetes, Gestational | 1 | 2017 | 112 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 3798 | 0.120 |
Why?
|
| Cambodia | 1 | 2015 | 10 | 0.120 |
Why?
|
| Genital Diseases, Female | 1 | 2016 | 31 | 0.120 |
Why?
|
| Fistula | 1 | 2016 | 49 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2016 | 258 | 0.110 |
Why?
|
| Transients and Migrants | 1 | 2015 | 31 | 0.110 |
Why?
|
| Depression | 1 | 2024 | 1313 | 0.110 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 225 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2016 | 363 | 0.110 |
Why?
|
| Pakistan | 3 | 2019 | 99 | 0.110 |
Why?
|
| Phlebotomy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 46 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2015 | 247 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 167 | 0.100 |
Why?
|
| Viremia | 1 | 2014 | 130 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1219 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 337 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 4035 | 0.090 |
Why?
|
| Hospitalization | 1 | 2021 | 1933 | 0.090 |
Why?
|
| Quality of Health Care | 1 | 2015 | 408 | 0.090 |
Why?
|
| Spouses | 1 | 2013 | 71 | 0.090 |
Why?
|
| Vaccination | 1 | 2017 | 1051 | 0.090 |
Why?
|
| Focus Groups | 1 | 2013 | 232 | 0.090 |
Why?
|
| Hospitals | 1 | 2014 | 437 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2019 | 12834 | 0.080 |
Why?
|
| Infant | 5 | 2023 | 13228 | 0.080 |
Why?
|
| Double-Blind Method | 3 | 2019 | 1621 | 0.080 |
Why?
|
| Pleasure | 1 | 2010 | 10 | 0.080 |
Why?
|
| Condoms | 1 | 2010 | 47 | 0.080 |
Why?
|
| Culture | 1 | 2010 | 69 | 0.080 |
Why?
|
| Rural Population | 1 | 2013 | 272 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2011 | 163 | 0.080 |
Why?
|
| Income | 1 | 2010 | 137 | 0.080 |
Why?
|
| Job Satisfaction | 1 | 2010 | 100 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 430 | 0.080 |
Why?
|
| Developing Countries | 3 | 2019 | 302 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 2088 | 0.070 |
Why?
|
| Time Factors | 2 | 2018 | 6200 | 0.070 |
Why?
|
| Tanzania | 2 | 2019 | 66 | 0.070 |
Why?
|
| Uganda | 2 | 2019 | 83 | 0.070 |
Why?
|
| Marital Status | 1 | 2008 | 33 | 0.070 |
Why?
|
| Public Health Administration | 1 | 2007 | 9 | 0.070 |
Why?
|
| Public Health Practice | 1 | 2007 | 19 | 0.070 |
Why?
|
| Violence | 1 | 2009 | 128 | 0.070 |
Why?
|
| National Health Programs | 1 | 2007 | 20 | 0.070 |
Why?
|
| Crime Victims | 1 | 2009 | 76 | 0.070 |
Why?
|
| Endemic Diseases | 1 | 2007 | 60 | 0.070 |
Why?
|
| Life Style | 1 | 2010 | 444 | 0.070 |
Why?
|
| Africa, Southern | 1 | 2007 | 6 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 412 | 0.060 |
Why?
|
| Circumcision, Male | 1 | 2007 | 22 | 0.060 |
Why?
|
| Aggression | 1 | 2009 | 218 | 0.060 |
Why?
|
| Social Class | 1 | 2008 | 211 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2019 | 3113 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2019 | 708 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2569 | 0.060 |
Why?
|
| Child | 3 | 2023 | 26094 | 0.050 |
Why?
|
| Surgical Wound Infection | 1 | 2007 | 263 | 0.050 |
Why?
|
| Social Marginalization | 1 | 2024 | 2 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6424 | 0.050 |
Why?
|
| Chloroquine | 1 | 1984 | 30 | 0.050 |
Why?
|
| Africa South of the Sahara | 2 | 2019 | 121 | 0.050 |
Why?
|
| Sex Factors | 1 | 2007 | 1338 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 20888 | 0.050 |
Why?
|
| Student Health Services | 1 | 2023 | 3 | 0.050 |
Why?
|
| Universities | 1 | 2023 | 127 | 0.050 |
Why?
|
| Law Enforcement | 1 | 2021 | 18 | 0.040 |
Why?
|
| Risk Factors | 3 | 2023 | 10948 | 0.040 |
Why?
|
| Prevalence | 3 | 2018 | 2683 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2011 | 8519 | 0.040 |
Why?
|
| Incidence | 1 | 2007 | 3313 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2023 | 335 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2021 | 1209 | 0.040 |
Why?
|
| Urinalysis | 1 | 2018 | 73 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 2018 | 48 | 0.030 |
Why?
|
| Microscopy | 1 | 2018 | 118 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 93 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 547 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 723 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2018 | 154 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6788 | 0.030 |
Why?
|
| Vaginal Fistula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1157 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 809 | 0.030 |
Why?
|
| Urinary Incontinence | 1 | 2016 | 66 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 551 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1270 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1287 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2017 | 1444 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2007 | 14943 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2011 | 238 | 0.020 |
Why?
|
| Philippines | 1 | 2009 | 22 | 0.020 |
Why?
|
| Schools | 1 | 2009 | 236 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2007 | 173 | 0.020 |
Why?
|
| United States | 1 | 2021 | 11874 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2007 | 443 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 2074 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1984 | 195 | 0.010 |
Why?
|
| Plasmodium falciparum | 1 | 1984 | 81 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 3675 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 33857 | 0.010 |
Why?
|